Toward quantitative neuroimaging biomarkers for Friedreich's ataxia at 7 Tesla: Susceptibility mapping, diffusion imaging, R (2) and R (1) relaxometry

Friedreich's ataxia (FRDA) is a rare genetic disorder leading to degenerative processes. So far, no effective treatment has been found. Therefore, it is important to assist the development of medication with imaging biomarkers reflecting disease status and progress. Ten FRDA patients (mean age...

Descripción completa

Detalles Bibliográficos
Autores principales: Straub, Sina, Mangesius, Stephanie, Emmerich, Julian, Indelicato, Elisabetta, Nachbauer, Wolfgang, Degenhardt, Katja S., Ladd, Mark E., Boesch, Sylvia, Gizewski, Elke R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590084/
https://www.ncbi.nlm.nih.gov/pubmed/32731306
http://dx.doi.org/10.1002/jnr.24701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590084/
https://www.ncbi.nlm.nih.gov/pubmed/32731306
http://dx.doi.org/10.1002/jnr.24701

Ejemplares similares